8-K 1 b46332zme8vk.txt ZOLL MEDICAL CORP. UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): April 17, 2003 ZOLL MEDICAL CORPORATION (Exact Name of Registrant as Specified in Charter) Massachusetts 000-20225 04-2711626 (State or Other Jurisdiction (Commission File (IRS Employer of Incorporation) Number) Identification No.) 32 Second Avenue, Northwest Park, Burlington, Massachusetts 01803 (Address of principal executive offices) (781) 229-0020 (Registrant's telephone number, including area code) ITEM 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS (c) Exhibits EXHIBIT NO. DESCRIPTION ----------- ----------- 99.1 Press release issued April 17, 2003 ITEM 9. REGULATION FD DISCLOSURE The following information is being provided under Item 12 - Results of Operations and Financial Condition. On April 17, 2003, ZOLL Medical Corporation issued the press release attached to this Form 8-K as Exhibit 99.1. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: April 17, 2003 ZOLL MEDICAL CORPORATION By: /s/ Richard A. Packer --------------------------- Name: Richard A. Packer Title: Chairman and Chief Executive Officer